Skip to main content

Mitral Valve Prolapse Echo and Auscultation

Mitral Valve Prolapse: A Comprehensive Review



Mitral Valve Prolapse (MVP) is a common valvular heart condition characterized by the displacement of the mitral valve leaflets into the left atrium during systole. This article provides an in-depth look at the diagnosis, echo findings, and auscultation maneuvers used to identify MVP.


Pathophysiology


In MVP, the mitral valve leaflets bulge backward into the left atrium due to:


1. Myxomatous degeneration: Thickening and redundancy of the valve leaflets.

2. Chordal elongation: Stretching or rupture of the chordae tendineae.


Echo Findings


Echocardiography is the primary diagnostic tool for MVP. Key findings include:


1. Leaflet displacement: > 2 mm displacement of the leaflets beyond the mitral annular plane.

2. Leaflet thickening: Thickening of the leaflets (> 5 mm).

3. Mitral regurgitation: Color Doppler assessment of regurgitant flow.

4. Left atrial enlargement: Enlargement of the left atrium due to chronic regurgitation.


Auscultation Maneuvers


Physical examination plays a crucial role in diagnosing MVP. Auscultation maneuvers include:


1. Mid-systolic click: A high-pitched sound heard best at the apex.

2. Late systolic murmur: A murmur that peaks in late systole, often associated with mitral regurgitation.

3. Valsalva maneuver: Decreases left ventricular volume, increasing the intensity of the murmur.

4. Squatting: Increases left ventricular volume, decreasing the intensity of the murmur.


Clinical Implications


MVP can lead to:


1. Mitral regurgitation: Chronic regurgitation can lead to left ventricular dysfunction.

2. Atrial fibrillation: Increased risk of arrhythmias due to left atrial enlargement.

3. Endocarditis: Increased risk of infective endocarditis.


Management


Treatment strategies for MVP include:


1. Monitoring: Regular echocardiographic follow-up.

2. Medications: Beta blockers or anti-arrhythmics for symptom management.

3. Surgery: Mitral valve repair or replacement in severe cases.


By understanding the technical aspects of MVP, clinicians can provide accurate diagnoses and effective management strategies for patients with this condition.


Visit Echo Library 


Mitral Valve Prolapse (MVP) and Flail Mitral Valve (FMV) are both conditions affecting the mitral valve, but they have distinct differences:


Key Differences


1. Leaflet Motion:

    - MVP: Leaflets bulge backward into the left atrium during systole, but still coapt.

    - FMV: Leaflet or chordae rupture, resulting in severe mitral regurgitation and loss of coaptation.

2. Regurgitation Severity:

    - MVP: Typically mild to moderate mitral regurgitation.

    - FMV: Severe mitral regurgitation due to loss of leaflet coaptation.

3. Echocardiographic Findings:

    - MVP: Leaflet displacement > 2 mm beyond the mitral annular plane.

    - FMV: Visible leaflet or chordae rupture, with severe mitral regurgitation and often a large regurgitant jet.

4. Clinical Presentation:

    - MVP: May be asymptomatic or present with mild symptoms.

    - FMV: Often presents with severe symptoms, such as dyspnea, fatigue, and palpitations, due to acute or severe mitral regurgitation.


Diagnostic Evaluation


1. Echocardiography: Transthoracic echocardiogram (TTE) or transesophageal echocardiogram (TEE) can help diagnose MVP and FMV.

2. Imaging: Careful evaluation of leaflet motion, coaptation, and regurgitant jet severity can help differentiate between MVP and FMV.


Accurate diagnosis and differentiation between MVP and FMV are crucial for guiding management decisions and determining the need for surgical intervention.




#Echocardiography

#Cardiology



Comments

Popular posts from this blog

Learn Echocardiography | Standard Protocol for Performing Comprehensive Echocardiogram | Explained with Images and Videos

  If you are just starting to learn echocardiography, you will find that learning the full echo examination protocol will be immensely useful. The full protocol will provide a solid foundation for your career in echo. I personally found that once I could execute the standard protocol flawlessly, I was able to add and refine additional echo scanning skills while deepening my understanding of the purpose of each echo image. The echo protocol illustrated in this article is the same one we currently use for all our patients in the hospital and meets or exceeds the standards of American Society of Echocardiography (ASE) for an adult echocardiography examination. The protocol presented here is meant as a guideline and does not cover every aspect (such as off axis views) of an echo examination. Also other hospitals will probably have slight variations of this protocol depending on the lab's needs, which is normal. This article's main purpose is to provide a solid foundation for ...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

What is Duke treadmill Score (DTS) and How to calculate it?

Watch this simple video on DTS calculation with example case:   Commonly asked questions: How to Calculate Duke treadmill Score? What is DTS? How to risk stratify a patient with ETT (Exercise Tolerance Test)? #Cardiology #Non-Invasive risk Stratification